Johnson & Johnson’s Cordis Corporation Escapes $482 Million Verdict As Court Rejects Patent Appeal

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The U.S. Supreme Court on Monday declined to hear an appeal from a radiologist seeking to reinstate a $482 million patent infringement award he had won against Cordis Corp. The decision leaves intact an appeals court ruling throwing out the 2011 jury award. In the April 2013 ruling, the U.S. Court of Appeals for the Federal Circuit said Cordis, a Johnson and Johnson subsidiary, did not infringe on a patent owned by the radiologist, Bruce Saffran, in making its Cypher stent.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC